Russia's Pharmsynthez plans IPO to expand business
This article was originally published in Scrip
Executive Summary
St Petersburg-based Pharmsynthez has set an indicative price range of between Rb20.6 ($0.67) and Rb27.7 per ordinary share for its initial public offering on the innovation and investments market on the Moscow Interbank Currency Exchange (MICEX) at the end of November. The IPO will comprise around 23 million ordinary shares representing around one third of its nominal capital.